BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Biotech

Novavax and SII Announce First EUA of Novavax' COVID-19 Vaccine in Adolescents ≥12 to <18 in India

Covovax™ (SARS-CoV-2 rS Protein (COVID-19) recombinant spike protein Nanoparticle Vaccine) is the first protein-based COVID-19 vaccine authorized&n...

March 23, 2022 | News

Genscript Biotech Reports 2021 Annual Results

Revenue of the Group for the year ended December 31, 2021 was approximately US$511.1 million, representing an increase of 30.8% as compare...

March 21, 2022 | News

KKR-backed Biosynth Carbosynth Acquires vivitide

Combination of Biosynth Carbosynth and vivitide creates global life sciences platform serving high-growth biopharma and diagnostics end markets KKR, a lea...

March 18, 2022 | News

Toxys Opens US Office and Production Facility to Accelerate Growth

With these new facilities, Toxys will be able to better serve its clients in North America and make the Toxys assays readily available. The opening of an ...

March 17, 2022 | News

KHIDI Presenting the latest healthcare technologies with leading innovation companies of South Korea

Korea Health Industry Development Institute (KHIDI) announced its operation of the Korean pavilion at the 2022 HIMSS Global Health Conference & Ex...

March 16, 2022 | News

China NMPA Approves Tislelizumab for Patients with Microsatellite Instability-High or Mismatch Repair-Deficient Solid Tumors

-BeiGene, Ltd. , a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and...

March 14, 2022 | News

Sinocompound announces commercial-scale production of QPhos ligand

Sinocompound Catalysts Co., Ltd, a global provider of advanced homogeneous catalysts and ligands, has announced production of the phosphine-based QPhos lig...

March 14, 2022 | News

Terran Biosciences announces acquisition of a portfolio of novel CNS therapeutics from Concert Pharmaceuticals

These deuterated compounds represent next-generation therapeutics with applications across several different psychiatric and neurological conditions. Terra...

March 13, 2022 | News

Exclusive license for Croda to commercialise SSI’s CAF® vaccine adjuvants

Croda International Plc, which uses smart science to improve lives, announces today that it has entered a strategic collaboration with Statens Serum Instit...

March 04, 2022 | News

Thermo Fisher Scientific Continues Collaboration to Support Biopharmaceutical Discovery and Development

Thermo Fisher Scientific, the world leader in serving science, and Symphogen, an affiliate of and the antibody center of excellence within the internationa...

March 01, 2022 | News

First Japanese Institution to Utilize SOPHiA GENETICS' Myeloid Plus Solution

Hiroshima University is home to one of the largest university research institutes in the field of radiation biomedical science in Japan. With NGS...

February 23, 2022 | News

Thermo Fisher Scientific Expands Millersburg, Pa. Bioprocessing Manufacturing Site

hermo Fisher Scientific is investing $40 million to expand its single-use technology (SUT) manufacturing facility in Millersburg, Pa. The expansion is part...

February 18, 2022 | News

Moderna Announces Plan to Expand Footprint in Asia with Four Additional Subsidiaries

Moderna, Inc., (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced plans to expand its comme...

February 16, 2022 | News

Nuvaxovid™ is the first protein-based COVID-19 vaccine authorized for use in Singapore

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases,...

February 15, 2022 | News

Stay Connected